A trend suggesting that high RAF1 expression is associated with tumor progression within the MSI group was observed (Supplementary Fig. S8D), although it did not reach significance with a Fisher test (p = 0.1), probably due to the small number of patients for which we obtained clinical history (Supplementary Table 4). This evidence concerns the gene RAF1 and neoplasm.